Digital Pathology Industry Future of Pathology
Digital pathology involves converting glass slides into digital slides that can be observed, managed, shared, and examined on a computer monitor. With the influx of whole-slide imaging, the framework of digital pathology saw huge growth and is currently regarded as one of the most promising avenues of diagnostic medicine.
The global market for digital pathology is estimated to show a growth owing to a dearth of pathologists in the presence of cumulative demand for healthcare services, benefits associated with the use of digital pathology, increasing adoption of Electronic Health Records (EHR), and cost saving associated with the application of digital pathology. However, factors such as the high cost of implementation and stringent FDA policies are expected to restrict the market growth over the forecast period.
The global digital pathology market is expected to reach a market value of USD 8,305.6 million by 2023 from USD 3,937 million in 2017 and is expected to register a CAGR of 13.04% during the forecast period from 2018 to 2023.
In 2017, the Americas held the highest share of the market at 45.3%, followed by Europe and Asia-Pacific with shares of 26.2% and 21.3%, respectively. The increasing applications of digital pathology are expected to increase the growth of the market during the forecast period.
Key Players of Industry
Koninklijke Philips N.V., Olympus Corporation of the Americas, Danaher Corporation (Leica Biosystems GmbH), Inspirata, 3DHISTECH Ltd., Definiens, Huron Digital Pathology Inc, F. Hoffmann-La Roche Ltd, micro dimensions GmbH, and Mikroscan Technologies, Inc.
Key Findings
• The global digital pathology market is expected to reach USD 8,305.6 million by 2023 at a CAGR of 13.04% from 2018 to 2023
• On the basis of type, the human pathology segment is expected to account for the largest market share at a CAGR of 13.32% by 2023
• On the basis of product, the hardware segment is expected to account for the largest market share at a CAGR of 13.37% by 2023
• On the basis of application, the disease diagnosis segment is expected to account for the largest market share at a CAGR of 13.27% by 2023
• On the basis of end user, the research centers and academic institutes segment is expected to account for the largest market share at a CAGR of 13.34% by 2023
• The Americas is expected to hold the largest share of the global digital pathology market at a CAGR of 13.27% by 2023
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 13.53% by 2023
Source inforgrowth.com/report/1489197/digital-pathology-market
About InForGrowth:
At InForGrowth, Understand Research requirements and help a client in taking informed business critical decisions. Given the complexities and interdependencies of market-intelligence, there is always more than one source to explore and arrive at the right answer. Through our smart search feature and our reliable and trusted publishing partners, we are paving way for a more simplified and relevant research.
